Oxymatrine can attenuate pathological deficits of Alzheimer's disease mice through regulation of neuroinflammation
Alzheimer's disease (AD) is a common neurodegenerative disorder characterized by progressive learning and cognitive damage. Several hypotheses such as amyloid cascade hypothesis, hyper-phosphorylated τ hypothesis, and energy metabolism hypothesis have been proposed to elucidate the disease. However, the exact mechanism of AD remains unclear and current therapeutic strategies are miserable. Cumulative evidence showed that neuroinflammation plays a significant role in the pathogenesis of the AD. Oxymatrine (OMT), a plant-derived bioactive compound, has anti-viral, anti-fibrosis, and anti-tumor effects through the involvement of several immune-related signaling pathways.
Source: Journal of Neuroimmunology - Category: Allergy & Immunology Authors: Yun Chen, Ziyou Qi, Baojun Qiao, Zhanyun Lv, Tinglei Hao, Hongfang Li Source Type: research
More News: Allergy & Immunology | Alzheimer's | Brain | Learning | Neurology | Universities & Medical Training